Increased Serum Level of CCL5 in Children with Attention-Deficit/Hyperactivity Disorder: First Results about Serum Chemokines

Creative Commons License

ÖZASLAN A., GÜNEY E., GÜLBAHAR Ö., Buyuktaskin D., Arslan B.

CLINICAL PSYCHOPHARMACOLOGY AND NEUROSCIENCE, cilt.20, sa.1, ss.109-117, 2022 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 20 Sayı: 1
  • Basım Tarihi: 2022
  • Doi Numarası: 10.9758/cpn.2022.20.1.109
  • Dergi Adı: CLINICAL PSYCHOPHARMACOLOGY AND NEUROSCIENCE
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, BIOSIS, EMBASE, Psycinfo
  • Sayfa Sayıları: ss.109-117
  • Anahtar Kelimeler: Attention deficit hyperactivity disorder, Neurodevelopmental disorders, Chemokine CCL5, Chemokines, PARKINSONS-DISEASE, NEUROINFLAMMATION, RECEPTORS, RANTES, MODEL, INFLAMMATION, PREVALENCE, BRAIN, NIGRA, CCR2
  • Gazi Üniversitesi Adresli: Evet

Özet

Objective: Attention deficit hyperactivity disorder (ADHD) is a neurodevelopmental disorder and its aetiology is not fully understood. This study aimed to determine whether the CCL5 and CCL11 influence the ADHD aetiology by comparing serum CCL5 and CCL11 levels of children with ADHD and typical development.